Your browser doesn't support javascript.
loading
Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.
Yu, K-H; Lai, J-H; Hsu, P-N; Chen, D-Y; Chen, C-J; Lin, H-Y.
Afiliación
  • Yu KH; a Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine , Chang Gung Memorial Hospital and Chang Gung University , Taoyuan , Taiwan , ROC.
  • Lai JH; b Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine , Chang Gung Memorial Hospital, Chang Gung University and School of Medicine, National Defense Medical Center , Taipei , Taiwan , ROC.
  • Hsu PN; c Department of Internal Medicine , National Taiwan University Hospital , Taipei , Taiwan , ROC.
  • Chen DY; d Faculty of Medicine , National Yang-Ming University , Taipei , Taiwan , ROC.
  • Chen CJ; e Department of Medical Education and Research , Taichung Veterans General Hospital , Taichung , Taiwan , ROC.
  • Lin HY; f Institute of Biomedical Science , National Chung-Hsing University , Taichung , Taiwan , ROC.
Scand J Rheumatol ; 45(4): 304-11, 2016 Jul.
Article en En | MEDLINE | ID: mdl-26771445

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Supresores de la Gota / Hiperuricemia / Febuxostat / Gota Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Scand J Rheumatol Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Supresores de la Gota / Hiperuricemia / Febuxostat / Gota Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Scand J Rheumatol Año: 2016 Tipo del documento: Article